Making Stem Cells
Compatible
with Everyone
Editing Stem Cells to Cure Disease
rAAV
Universal Cells creates Universal Donor Stem Cells by editing the genes required for immune recognition. By using our recombinant Adeno-Associated Virus (rAAV) technology, we design and manufacture stem cell-based products that can be used as off-the-shelf cell therapies.
One Universal Stem Cell Bank
Universal Donor Cells are pluripotent and can differentiate into various cell types that can be used to treat a vast number of diseases. Learn more about the Universal Cells’ pipeline and partnerships.
Latest News
Universal Cells’ CEO wins Leadership Award
Seattle, WA – May 30th, 2017 – Universal Cells’ CEO and Co-founder, Claudia Mitchell received the Gold award in Leadership at the Seattle’s 3rd Annual French-American Business Awards event, held on Friday, May 12, 2017 [...]
Universal Cells’ Gene Editing Strategy Published in Nature Biotechnology
Seattle, WA – May 15th, 2017 – Universal Cells announced today that a report from Universal Cells’ CSO Dr. David Russell and researchers at the University of Washington demonstrating the potential of Universal [...]
Universal Cells to present at 5th Annual Cell & Gene Therapy Investor Day, April 27th in Boston
Seattle, WA – Universal Cells announced today that Claudia Mitchell, CEO will present at the Alliance for Regenerative Medicine’s 5th Annual Cell & Gene Therapy Investor Day on Thursday, April 27, 2017 at [...]